Article Versions Notes

ElMahdy MK, Antar SA, Elmahallawy EK, Abdo W, Hijazy HHA, Albrakati A, Khodir AE. A Novel Role of Dapagliflozin in Mitigation of Acetic Acid-Induced Ulcerative Colitis by Modulation of Monocyte Chemoattractant Protein 1 (MCP-1)/Nuclear Factor-Kappa B (NF-κB)/Interleukin-18 (IL-18). Biomedicines. 2022; 10(1):40. https://doi.org/10.3390/biomedicines10010040

ElMahdy, Mohamed Kh., Samar A. Antar, Ehab Kotb Elmahallawy, Walied Abdo, Hayfa Hussin Ali Hijazy, Ashraf Albrakati, and Ahmed E. Khodir. 2022. "A Novel Role of Dapagliflozin in Mitigation of Acetic Acid-Induced Ulcerative Colitis by Modulation of Monocyte Chemoattractant Protein 1 (MCP-1)/Nuclear Factor-Kappa B (NF-κB)/Interleukin-18 (IL-18)" Biomedicines 10, no. 1: 40. https://doi.org/10.3390/biomedicines10010040

ElMahdy, M. K., Antar, S. A., Elmahallawy, E. K., Abdo, W., Hijazy, H. H. A., Albrakati, A., & Khodir, A. E. (2022). A Novel Role of Dapagliflozin in Mitigation of Acetic Acid-Induced Ulcerative Colitis by Modulation of Monocyte Chemoattractant Protein 1 (MCP-1)/Nuclear Factor-Kappa B (NF-κB)/Interleukin-18 (IL-18). Biomedicines, 10(1), 40. https://doi.org/10.3390/biomedicines10010040